Prostate Cancer Clinical Trials

Showing 841-860 of 2,150 trials

Neoadjuvant Ipilimumab in Prostate Cancer

NCT01194271

The goal of this clinical research study is to learn how ipilimumab in combination with Lupron (leuprolide acetate) affects the body's own defense (immune) system before having surgery to remove prostate cancer. The safety of the drug combination will also be studied.

Prostate Cancer

M.D. Anderson Cancer Center19 participantsStarted Sep 2010

Houston, Texas, United States

Not Yet RecruitingNA

Multi-Modal Image Fusion for Precision Prostate Biopsy Navigation

NCT06441292

This study is a prospective randomized controlled clinical trial aimed at comparing the detection rates of clinically significant prostate cancer between conventional biopsy methods and AI-assisted biopsy methods in patients undergoing initial prostate biopsy who meet the indications for prostate biopsy.

Prostate Cancer

Shanghai East Hospital602 participantsStarted Jul 2024

Shanghai, China

COMPLETEDNA

Feasibility Study: Educational Genetic Test Video

NCT06166758

Assess whether introducing an educational video regarding the benefits, risks, and limitations of genetic testing affects prostate cancer patients' decisional conflict regarding receiving germline genetic testing.

Prostate CancerEducation

Virginia Commonwealth University14 participantsStarted Dec 2023

Richmond, Virginia, United States

Neoadjuvant Ipilimumab in Prostate Cancer

Multi-Modal Image Fusion for Precision Prostate Biopsy Navigation

Feasibility Study: Educational Genetic Test Video

Related Searches

The Long Term Effect of MRI Before Radical Prostatectomy.

Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management

RAD 1801: Pilot Study of Intra-Urethral Radiotransponder Beacon Guided Focal Prostate Stereotactic Body Radiotherapy

PROstate CAncer Radiotherapy - Bowel Quality of Life (PROCAR-BQ)

Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate Cancer

Comparing Bp-MRI and Mp-MRI for Prostate Cancer Screening Accuracy

Neoadjuvant Listeria or Daratumumab in Prostate Cancer

Study of [177Lu] Lu-XT033 Injection in Patients With Metastatic Prostate Cancer

Hypofractionated SBRT For Prostate Cancer

Testing the Addition of Immunotherapy With Hu5F9-G4 (Magrolimab) to the Usual PARP Inhibitor, Olaparib for Treatment of Metastatic or Recurrent Breast or Castrate-Resistant Prostate Cancer With BRCA Mutations

[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application_2

Comparison of Analgesia Efficacy of Transversus Abdominis Plane Block and Posterior Approach Quadratus Lumborum Block

Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)

Abiraterone Acetate in Combination With Tildrakizumab

Dose-escalating Trial With UniCAR02-T Cells and PSMA Target Module (TMpPSMA) in Patients With Progressive Disease After Standard Systemic Therapy in Cancers With Positive PSMA Marker

Data Collection in Lutetium Treated Prostate Cancer: Recording of Progression and Tumor Characteristics

Clinical Study of Safety and Efficacy of Enhanced PSMA CAR- T in Refractory CRPC